Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- 18F Flurpiridaz PET MPI: New Horizons in Cardiac ImagingFluorine-18 (18F) flurpiridaz is a radiotracer for positron emission tomography (PET) myocardial perfusion imaging (MPI) newly approved by the Food and Drug Administration (FDA), offering several advantages due to its favorable physical properties.
- Proposed 2026 Medicare Physician Fee Schedule: An ACC Advocacy Deep DiveThe Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) proposed rule, updating the PFS conversion factor from $32.3465 to $33.5875 for qualifying alternative payment model (APM) participants and $33.4209 for non-qualifying APM participants...
- Increased Use of Radial Access For PCI in the US, Lower Complication Rates | NCDR StudyPCI with radial access site is associated with lower rates of in-hospital mortality, major access site bleeding and other major vascular complications vs. femoral access site and has increased in use in the U.S. over the past decade, overtaking femoral access site...
- Peripheral Interventions: Drug-Coated Balloon Endovascular Therapy and Transcatheter Arterialization of Deep VeinsDrug-coated ballon (DCB) endovascular therapy was found to be a reasonable treatment for femoropopliteal lesions in patients on hemodialysis, according to research published July 14 in JACC: Cardiovascular Interventions.
- AV after TTVR; Deep Learning in Automating Cardiac IMG; Survival Benefits Post-2018 Heart Transplantation Policy ChangeIn this week’s View, Dr. Eagle looks at predictors of high-grade atrioventricular block (AV) after transcatheter tricuspid valve replacement (TTVR).